| PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells A Boire, L Covic, A Agarwal, S Jacques, S Sherifi, A Kuliopulos Cell 120 (3), 303-313, 2005 | 1035 | 2005 |
| Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer Q Chen, A Boire, X Jin, M Valiente, EE Er, A Lopez-Soto, L S. Jacob, ... Nature 533 (7604), 493-498, 2016 | 835 | 2016 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 393 | 2020 |
| Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid EI Pentsova, RH Shah, J Tang, A Boire, D You, S Briggs, A Omuro, X Lin, ... Journal of clinical oncology 34 (20), 2404, 2016 | 359 | 2016 |
| Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ... Cell 185 (3), 563-575. e11, 2022 | 307 | 2022 |
| Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site V Trivedi, A Boire, B Tchernychev, NC Kaneider, AJ Leger, K O'Callaghan, ... Cell 137 (2), 332-343, 2009 | 277 | 2009 |
| Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis A Boire, Y Zou, J Shieh, DG Macalinao, E Pentsova, J Massagué Cell 168 (6), 1101-1113. e13, 2017 | 276 | 2017 |
| Brain metastasis A Boire, PK Brastianos, L Garzia, M Valiente Nature Reviews Cancer 20 (1), 4-11, 2020 | 273 | 2020 |
| The evolving landscape of brain metastasis M Valiente, MS Ahluwalia, A Boire, PK Brastianos, SB Goldberg, EQ Lee, ... Trends in cancer 4 (3), 176-196, 2018 | 233 | 2018 |
| Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization EE Er, M Valiente, K Ganesh, Y Zou, S Agrawal, J Hu, B Griscom, ... Nature cell biology 20 (8), 966-978, 2018 | 228 | 2018 |
| Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis E Yang, A Boire, A Agarwal, N Nguyen, K O'Callaghan, P Tu, A Kuliopulos, ... Cancer research 69 (15), 6223-6231, 2009 | 178 | 2009 |
| Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis Y Chi, J Remsik, V Kiseliovas, C Derderian, U Sener, M Alghader, ... Science 369 (6501), 276-282, 2020 | 172 | 2020 |
| Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications A Boire, D Brandsma, PK Brastianos, E Le Rhun, M Ahluwalia, L Junck, ... Neuro-oncology 21 (5), 571-584, 2019 | 139 | 2019 |
| Genomic correlates of disease progression and treatment response in prospectively characterized gliomas P Jonsson, AL Lin, RJ Young, NM DiStefano, DM Hyman, BT Li, ... Clinical Cancer Research 25 (18), 5537-5547, 2019 | 126 | 2019 |
| Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis A Morikawa, L Jordan, R Rozner, S Patil, A Boire, E Pentsova, ... Clinical breast cancer 17 (1), 23-28, 2017 | 116 | 2017 |
| Frequency and outcomes of brain metastases in patients with HER2‐mutant lung cancers M Offin, D Feldman, A Ni, ML Myers, WV Lai, E Pentsova, A Boire, ... Cancer 125 (24), 4380-4387, 2019 | 102 | 2019 |
| Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors X Lin, M Fleisher, M Rosenblum, O Lin, A Boire, S Briggs, Y Bensman, ... Neuro-oncology 19 (9), 1248-1254, 2017 | 102 | 2017 |
| Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients J Remsik, JA Wilcox, NE Babady, TA McMillen, BA Vachha, NA Halpern, ... Cancer Cell 39 (2), 276-283. e3, 2021 | 79 | 2021 |
| Clinical trial of proton craniospinal irradiation for leptomeningeal metastases TJ Yang, NA Wijetunga, J Yamada, S Wolden, M Mehallow, DA Goldman, ... Neuro-oncology 23 (1), 134-143, 2021 | 74 | 2021 |
| Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer M Tello-Lafoz, K Srpan, EE Sanchez, J Hu, J Remsik, Y Romin, A Calò, ... Immunity 54 (5), 1037-1054. e7, 2021 | 66 | 2021 |
Joan MassagueMemorial Sloan Kettering Cancer Cencer在 mskcc.org 的电子邮件经过验证
